These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Agents against cytokine synthesis or receptors. Yamagata T; Ichinose M Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805 [TBL] [Abstract][Full Text] [Related]
3. Targeting cytokines to tumors to induce active antitumor immune responses by recombinant fusion proteins. Xiang J Hum Antibodies; 1999; 9(1):23-36. PubMed ID: 10331183 [TBL] [Abstract][Full Text] [Related]
4. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model. Pallua N; Low JF; von Heimburg D Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624 [TBL] [Abstract][Full Text] [Related]
5. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines. Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470 [TBL] [Abstract][Full Text] [Related]
6. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors. Khawli LA; Hu P; Epstein AL Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951 [TBL] [Abstract][Full Text] [Related]
7. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction. Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399 [TBL] [Abstract][Full Text] [Related]
8. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages. Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537 [TBL] [Abstract][Full Text] [Related]
9. New therapies for inflammatory bowel disease: an update on chimeric anti-TNF alpha antibodies and IL-10 therapy. van Hogezand RA; Verspaget HW Scand J Gastroenterol Suppl; 1997; 223():105-7. PubMed ID: 9200315 [TBL] [Abstract][Full Text] [Related]
10. Pro-inflammatory cytokines and interleukin 6 in the renal response to bacterial endotoxin. Kayama F; Yoshida T; Kodama Y; Matsui T; Matheson JM; Luster MI Cytokine; 1997 Sep; 9(9):688-95. PubMed ID: 9325018 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of allograft rejection and organ-specific autoimmune disease by anti-interleukin-2 receptor (IL-2R)-targeted immunotherapy. The action of anti-IL-2R monoclonal antibodies and synergistic effect of cyclosporin A. Diamantstein T; Mouzaki A; Osawa H; Volk HD; Hahn HJ; Kirkman RL; Strom TB; Tilney NL; Kupiec-Weglinski JW Dev Biol Stand; 1988; 69():177-84. PubMed ID: 3066671 [No Abstract] [Full Text] [Related]
12. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. Piccotti JR; Chan SY; Goodman RE; Magram J; Eichwald EJ; Bishop DK J Immunol; 1996 Sep; 157(5):1951-7. PubMed ID: 8757314 [TBL] [Abstract][Full Text] [Related]
13. Anti-CD25 monoclonal antibody modulates cytokine expression and prolongs allografts survival in rats cardiac transplantation. Xia J; Jiang X; Huang Y; Zhang K; Xiao S; Yang C Chin Med J (Engl); 2003 Mar; 116(3):432-5. PubMed ID: 12781053 [TBL] [Abstract][Full Text] [Related]
14. A humanized monoclonal antibody against interleukin-2 that can inactivate the cytokine/receptor complex. Volkland J; Lumsden J; Mølhøj M; Raum T; Hausmann S; Wissing S; Wissinger M; Hoffmann P; Sriskandarajah M; Kvesic M; Baeuerle PA; Pflanz S Mol Immunol; 2007 Mar; 44(7):1743-53. PubMed ID: 17000002 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis. Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282 [TBL] [Abstract][Full Text] [Related]
16. Humanized antibodies against the alpha-chain of the IL-2 receptor and against the beta-chain shared by the IL-2 and IL-15 receptors in a monkey uveitis model of autoimmune diseases. Guex-Crosier Y; Raber J; Chan CC; Kriete MS; Benichou J; Pilson RS; Kerwin JA; Waldmann TA; Hakimi J; Roberge FG J Immunol; 1997 Jan; 158(1):452-8. PubMed ID: 8977222 [TBL] [Abstract][Full Text] [Related]
17. The mode of action of cytokine inhibitors. Arend WP J Rheumatol Suppl; 2002 Sep; 65():16-21. PubMed ID: 12236617 [TBL] [Abstract][Full Text] [Related]
18. Anti-CD25 monoclonal antibody therapy affects the death signals of graft-infiltrating cells after clinical heart transplantation. Baan CC; Balk AH; van Riemsdijk IC; Vantrimpont PJ; Maat AP; Niesters HG; Zondervan PE; van Gelder T; Weimar W Transplantation; 2003 May; 75(10):1704-10. PubMed ID: 12777860 [TBL] [Abstract][Full Text] [Related]
19. [Cytokines and soluble cytokine receptors in the perioperative period]. Maruna P; Gürlich R; Frasko R; Chachkhiani I; Marunová M; Owen K; Pesková M Sb Lek; 2002; 103(2):273-82. PubMed ID: 12688152 [TBL] [Abstract][Full Text] [Related]
20. Preclinical and clinical development of immunocytokines. Sondel PM; Hank JA; Gan J; Neal Z; Albertini MR Curr Opin Investig Drugs; 2003 Jun; 4(6):696-700. PubMed ID: 12901228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]